EUROPE AMNIOTIC MEMBRANE MARKET 2022-2028
MARKET OUTLOOK
Triton Market Research’s report that the amniotic membrane market in Europe will progress at a CAGR of 6.91% during the forecasting years 2022-2028. Russia, the United Kingdom, France, Spain, Germany, Italy, and the Rest of Europe shape the market in this region.
The rise in research and development activities supports the studied market’s growth in the United Kingdom. Several research hospitals have commenced their offering of amniotic membrane treatment in ophthalmology. Moreover, advancements in medical instruments have surged amniotic membrane application in various treatments. Amniotic membrane application in bone transformation, construction, and repair has emerged as the most beneficial among various treatments. Furthermore, the National Health Service Program initiated voluntary placenta donation, which is expected to further drive the amniotic membrane market across the country.
Similarly, several hospitals offer amniotic membrane treatments and transplants in France. Moreover, many hospitals are advancing their procedures with the deployment of the latest technologies. For instance, La Clinique de L’infirmerie Prostestante introduced robotic-assisted surgery and opened a thoracic pain unit. It has also been certified by the National Health Authority, an authority that assesses the quality of care in hospitals. Therefore, the development in medical facilities and treatments is expected to widen the scope and growth of the amniotic membrane market in France.
COMPETITIVE OUTLOOK
Leading companies thriving in the amniotic membrane market include Bio Tissue Inc, Amino Technology LLC, Katena Products Inc, Labtician Ophthalmics Inc, and MiMedx.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook